Gene therapy restores partial vision in inherited blindness patients

Image credit: cdc via Unsplash

A new study published in the New England Journal of Medicine reports that a CRISPR gene-editing tool has been linked to noticeable improvements in restoring partial vision for patients suffering from inherited blindness. This study marks the first time that CRISPR has been applied directly to the eyes of living people. While the therapy remains in the experimental stage, these promising results need to be replicated in larger-scale clinical trials. This innovative therapy brings new hope for those affected by these previously untreatable conditions and paves the way for future gene therapies in treating various inherited disorders.

Source

Howard, Jacqueline. “Experimental Gene Therapy Restores Some Vision in Patients with Inherited Blindness.” CNN, Cable News Network, 6 May 2024, www.cnn.com/2024/05/06/health/gene-editing-blindness-study-scn?utm_term=1715118004084fa8e166b1bdb&utm_source=cnn_05.07.24%2BResults%2BAre%2BIn&utm_medium=email&bt_ee=yBiT5rDTCY6jydl16vN8sj6IStyT4KgQCAckv5jrYpHWuXm9HrRaEOiHx2t5mRqU&bt_ts=1715118004087.